Skip to main content

Regeniq vs Peptides Direct

Two Australian telehealth providers. Different prescribing models. Compare practitioners, pricing, consultation requirements, and corporate transparency before you choose.

Side-by-side comparison

Clear corporate entity disclosed

Regeniq

Regeniq Pty Ltd (ABN 41 694 432 865), named on the Regeniq About and complaints pages.

Peptides Direct

Operating entity is Cosmetics 2U Pty Ltd. Not prominently disclosed on the website.

How fees are shown

Regeniq

Consultation fees are listed by pathway on the Regeniq pricing page, before you sign up.

Peptides Direct

Consultation fees published. Medication prices not publicly listed.

Named scientific advisor

Regeniq

Education content calibrated by Scientific Advisor Dr. Mitchell Henry Wright, PhD (Microbiology).

Peptides Direct

No named content authors or scientific advisors identified.

Documented TGA/AHPRA enforcement actions

Regeniq

None.

Peptides Direct

None found as of March 2026.

About Peptides Direct

Overview

Peptides Direct is an Australian telehealth service operated by Cosmetics 2U Pty Ltd, a company registered in 2012. The service markets to both men and women and offers telehealth consultations via Zoom or phone before prescribing from approved product categories.

Prescribing model

You register and complete a medical questionnaire. A pre-screening process includes mandatory pathology (blood tests). A doctor conducts a telehealth consultation via Zoom or phone, then builds a personalised treatment plan. Re-orders do not require an additional consultation. Orders are reviewed by a medical team at the time of ordering.

Pricing transparency

Consultation fees are publicly displayed, with one fee where pathology from the past six months exists and another that includes a pathology referral. Medication prices are not publicly listed. Flat-rate shipping applies.

Practitioner transparency

No AHPRA registration numbers are displayed. The website refers to an 'experienced Medical Team' without naming its prescribing doctors.

Regulatory compliance

Information current as of 18 March 2026

TGA status

No documented TGA enforcement actions found as of 18 March 2026.

AHPRA status

Prescribing practitioners are not named and no AHPRA registration numbers are displayed on the public website as of 18 March 2026.

Observations

  • Prescribing practitioners are not named on the public website and no AHPRA registration numbers are displayed as of 18 March 2026.
  • Repeat prescriptions are processed without requiring a new consultation.
  • No refund policy applies to compounded prescription medications once dispatched.

How Regeniq works

Consultation fees shown by pathway

Consultation fees for each pathway are listed on the Regeniq pricing page, so you can see them before you sign up.

A telehealth consultation with an independent practitioner

You speak with an independent AHPRA-registered practitioner in a telehealth consultation. Clinical decisions about your care are made by your practitioner.

Pathology only where your practitioner decides it is needed

If your practitioner decides pathology is needed for your assessment, they will arrange it. Not everyone needs it. Pathology is billed separately from your consultation.

A facilitation model

Regeniq facilitates telehealth consultations with independent AHPRA-registered practitioners. Regeniq does not prescribe, diagnose, compound or dispense. Clinical decisions are made by your practitioner.

Named Scientific Advisor

Regeniq's education content is calibrated by its Scientific Advisor, Dr. Mitchell Henry Wright, PhD (Microbiology). His qualifications and research profile are listed on the Regeniq team page.

Frequently asked questions

Consultation fees for each pathway are listed on the Regeniq pricing page before you sign up. Based on publicly available sources reviewed on 18 March 2026, Peptides Direct also publishes consultation fees and does not publicly list medication prices.

Regeniq facilitates telehealth consultations with independent AHPRA-registered practitioners. Regeniq does not prescribe, diagnose, compound or dispense. Clinical decisions are made by your practitioner.

Based on publicly available sources reviewed on 18 March 2026, Peptides Direct is operated by Cosmetics 2U Pty Ltd, a company registered in 2012. Regeniq is operated by Regeniq Pty Ltd (ABN 41 694 432 865).

All competitor information is based on publicly available sources reviewed on 18 March 2026. Practices may change without notice. If you find outdated information, contact us and we will update the page.

Related pages

Ready to take the next step? Get started with a consultation from an AHPRA-registered practitioner.

Get Started
A runner on a coastal road, with a warm hillside and the ocean behind.

By joining you agree to receive Regeniq emails. Unsubscribe any time. See our Privacy Policy.